Vista Pharmaceuticals share news, announcements and annual reports
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Vista Pharmaceuticals Ltd. · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 1994
Last close ₹6.21down ₹0.24 (3.72%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹6.45.
30 Oct: open ₹6.50, high ₹6.50, low ₹6.15
52-week range of traded prices to 30 Oct 2026
₹5.32Low, 16 Sep 2026₹10.29High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹38 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.05
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,884
Vista Pharmaceuticals board meetings
150 filed, newest first. Page 3 of 3.
May 2019
Mar 2019
Jan 2019
29 Jan · Board meeting
Meeting on 6 Feb 2019: quarterly results24 Jan · Board meeting
Dec 2018
27 Dec · Board meeting
26 Dec · Board meeting
Nov 2018
Aug 2018
Jun 2018
May 2018
10 May · Board meeting
Mar 2018
Feb 2018
Jan 2018
9 Jan · Board meeting
Dec 2017
7 Dec · Board meeting
Nov 2017
28 Nov · Board meeting
20 Nov · Board meeting
Sep 2017
30 Sep · Board meeting
Aug 2017
Jul 2017
21 Jul · Board meeting
May 2017
Apr 2017
Mar 2017
Feb 2017
Nov 2016
Oct 2016
Aug 2016
May 2016
14 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 27, 2016, inter alia, to consider and approve the Unaudited Financial ....
Feb 2016
9 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 09, 2016, inter alia, has considered and approved appointment of Mr. ....
Dec 2015
Jul 2015
2 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 02, 2015, inter alia, has transacted the following : 1. Split and ....
Jun 2015
12 Jun · Board meeting
May 2015
Apr 2015
20 Apr · Board meeting
Board of Directors of the Company at its meeting held on April 20, 2015, inter alia, has considered and approved the following: 1. ....
Feb 2015
11 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 06, 2015, has appointed Mr. N. V. Chalapathi Rao as Whole Time Director ....
Aug 2014
1 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 01, 2014, inter alia, approved the notice of the Annual General Meeting ....
Aug 2013
14 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 14, 2013, inter-alia, considered and approved the following: 1. ....
Oct 2012
1 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 01, 2012, inter alia, have considered & approved following: - ....